DNLI — DENALI THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.28% (2021 Q2)
Avg. % of fund
0.03%
First filed
2020 Q4
Last filed
2025 Q3
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 91,200 +61,200 +204.0% 0.01% $1.3M $14.52
2025 Q3 ADDED 30,000 +22,634 +307.3% 0.00% $436K $14.52
2025 Q3 REDUCED 7,366 -22,634 -75.4% 0.00% $107K $14.52
2024 Q4 UNCHANGED 30,000 — 0% 0.01% $611K $20.38
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNLI price (monthly, adj. close)

Other funds also holding DNLI

As of 2025 Q4 — sorted by position size

Crestline Management, LP 3Y 7Y 87.02% Lynx1 Capital Management LP 3Y 5.81% Casdin Capital, LLC 3Y 7Y 1.89% Palo Alto Investors LP 3Y 7Y 1.47% DAFNA Capital Management LLC 3Y 7Y 1.22% STEMPOINT CAPITAL LP 1.19% Monashee Investment Management LLC 3Y 7Y 0.85% Siren, L.L.C. 0.69% MASTERS CAPITAL MANAGEMENT LLC 3Y 7Y 0.67% PSP Research LLC 0.46%
← Back to Caption Management, LLC Holdings